{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:10:22Z","timestamp":1793211022615,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82073778"],"award-info":[{"award-number":["82073778"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Natural Science Fund for Distinguished Young Scholars","award":["82104106"],"award-info":[{"award-number":["82104106"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-02838-1","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T05:05:01Z","timestamp":1726117501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Preparation and effects of functionalized liposomes targeting breast cancer tumors using chemotherapy, phototherapy, and immunotherapy"],"prefix":"10.1186","volume":"22","author":[{"given":"Bowen","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Pian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuoya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshuang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonggao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhe","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingji","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"2838_CR1","doi-asserted-by":"publisher","first-page":"102339","DOI":"10.1016\/j.ctrv.2022.102339","volume":"104","author":"D Trapani","year":"2022","unstructured":"Trapani D, et al. Global challenges and policy solutions in breast cancer control. Cancer Treat Rev. 2022;104:102339.","journal-title":"Cancer Treat Rev"},{"key":"2838_CR2","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.2147\/IJN.S161426","volume":"13","author":"M Jin","year":"2018","unstructured":"Jin M, et al. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes. IJN Volume. 2018;13:2405\u201326.","journal-title":"IJN Volume"},{"key":"2838_CR3","first-page":"171","volume":"104","author":"KP Trayes","year":"2021","unstructured":"Trayes KP, Cokenakes SEH. Breast Cancer Treatment. Am Fam Physician. 2021;104:171\u20138.","journal-title":"Am Fam Physician"},{"key":"2838_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS, June CH, Langer R, Mitchell M. J. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18:175\u201396.","journal-title":"Nat Rev Drug Discov"},{"key":"2838_CR5","unstructured":"Combination. strategies with PD-1\/PD-L1 blockade: current advances and future directions - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/35062949\/"},{"key":"2838_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-020-01786-6","volume":"40","author":"W Fang","year":"2021","unstructured":"Fang W, et al. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8\u2009+\u2009T cell exclusion. J Exp Clin Cancer Res. 2021;40:4.","journal-title":"J Exp Clin Cancer Res"},{"key":"2838_CR7","unstructured":"Immune induction strategies. In metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/31086347\/"},{"key":"2838_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bbcan.2017.10.007","volume":"1869","author":"M Santoni","year":"2018","unstructured":"Santoni M, et al. Triple negative breast cancer: key role of Tumor-Associated macrophages in regulating the activity of anti-PD-1\/PD-L1 agents. Biochim Biophys Acta Rev Cancer. 2018;1869:78\u201384.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2838_CR9","doi-asserted-by":"publisher","first-page":"117437","DOI":"10.1016\/j.lfs.2020.117437","volume":"247","author":"S Bastaki","year":"2020","unstructured":"Bastaki S, et al. PD-L1\/PD-1 axis as a potent therapeutic target in breast cancer. Life Sci. 2020;247:117437.","journal-title":"Life Sci"},{"key":"2838_CR10","unstructured":"Structural Biology of the Immune Checkpoint Receptor PD-1. and Its Ligands PD-L1\/PD-L2 - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/28768162\/"},{"key":"2838_CR11","unstructured":"BMS-202. A PD-1\/PD-L1 inhibitor, decelerates the pro-fibrotic effects of fibroblasts derived from scar tissues via ERK and TGF\u03b21\/Smad signaling pathways - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/36169254\/"},{"key":"2838_CR12","doi-asserted-by":"publisher","first-page":"102597","DOI":"10.1016\/j.pdpdt.2021.102597","volume":"36","author":"L Lin","year":"2021","unstructured":"Lin L, Song X, Dong X, Li B. Nano-photosensitizers for enhanced photodynamic therapy. Photodiagnosis Photodyn Ther. 2021;36:102597.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"2838_CR13","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.3390\/ijms22136658","volume":"22","author":"BS Dash","year":"2021","unstructured":"Dash BS, Das S, Chen J-P. Photosensitizer-functionalized nanocomposites for light-activated Cancer Theranostics. Int J Mol Sci. 2021;22:6658.","journal-title":"Int J Mol Sci"},{"key":"2838_CR14","doi-asserted-by":"publisher","first-page":"e2103978","DOI":"10.1002\/adma.202103978","volume":"33","author":"Y Wan","year":"2021","unstructured":"Wan Y, Fu L-H, Li C, Lin J, Huang P. Conquering the Hypoxia limitation for photodynamic therapy. Adv Mater. 2021;33:e2103978.","journal-title":"Adv Mater"},{"key":"2838_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1517\/13543780802567250","volume":"18","author":"SB Reddy","year":"2009","unstructured":"Reddy SB, Williamson SK. Tirapazamine: a novel agent targeting hypoxic tumor cells. Expert Opin Investig Drugs. 2009;18:77\u201387.","journal-title":"Expert Opin Investig Drugs"},{"key":"2838_CR16","doi-asserted-by":"publisher","first-page":"700407","DOI":"10.3389\/fonc.2021.700407","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Zhao L, Li X-F. Targeting Hypoxia: Hypoxia-activated Prodrugs in Cancer Therapy. Front Oncol. 2021;11:700407.","journal-title":"Front Oncol"},{"key":"2838_CR17","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.3390\/molecules25235672","volume":"25","author":"B Almeida","year":"2020","unstructured":"Almeida B, Nag OK, Rogers KE, Delehanty JB. Recent progress in Bioconjugation strategies for liposome-mediated drug delivery. Molecules. 2020;25:5672.","journal-title":"Molecules"},{"key":"2838_CR18","doi-asserted-by":"publisher","first-page":"122056","DOI":"10.1016\/j.ijpharm.2022.122056","volume":"624","author":"S Wang","year":"2022","unstructured":"Wang S, et al. Hollow mesoporous silica nanoparticles-loaded ion-crosslinked bilayer films with excellent mechanical properties and high bioavailability for buccal delivery. Int J Pharm. 2022;624:122056.","journal-title":"Int J Pharm"},{"key":"2838_CR19","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/pharmaceutics15030820","volume":"15","author":"S Wang","year":"2023","unstructured":"Wang S, Meng S, Zhou X, Gao Z, Piao MG. pH-Responsive and mucoadhesive nanoparticles for enhanced oral insulin delivery: the Effect of Hyaluronic Acid with different molecular weights. Pharmaceutics. 2023;15:820.","journal-title":"Pharmaceutics"},{"key":"2838_CR20","doi-asserted-by":"publisher","first-page":"45882","DOI":"10.1021\/acsomega.2c05852","volume":"7","author":"AM Itoo","year":"2022","unstructured":"Itoo AM, Paul M, Padaga SG, Ghosh B, Biswas S. Nanotherapeutic intervention in photodynamic therapy for Cancer. ACS Omega. 2022;7:45882\u2013909.","journal-title":"ACS Omega"},{"key":"2838_CR21","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.2147\/IJN.S313339","volume":"16","author":"M Jin","year":"2021","unstructured":"Jin M, et al. Smart Polymeric nanoparticles with pH-Responsive and PEG-Detachable properties (II): Co-delivery of Paclitaxel and VEGF siRNA for synergistic breast Cancer Therapy in mice. IJN Volume. 2021;16:5479\u201394.","journal-title":"IJN Volume"},{"key":"2838_CR22","doi-asserted-by":"crossref","unstructured":"Hou Y. Targeted therapeutic effects of oral inulin-modified double-layered nanoparticles containing chemotherapeutics on orthotopic colon cancer. (2022).","DOI":"10.1016\/j.biomaterials.2022.121440"},{"key":"2838_CR23","doi-asserted-by":"publisher","first-page":"111452","DOI":"10.1016\/j.msec.2020.111452","volume":"119","author":"K Solak","year":"2021","unstructured":"Solak K, Mavi A, Y\u0131lmaz B. Disulfiram-loaded functionalized magnetic nanoparticles combined with copper and sodium nitroprusside in breast cancer cells. Mater Sci Engineering: C. 2021;119:111452.","journal-title":"Mater Sci Engineering: C"},{"key":"2838_CR24","doi-asserted-by":"publisher","first-page":"106085","DOI":"10.1016\/j.ejps.2021.106085","volume":"168","author":"S Wang","year":"2022","unstructured":"Wang S, et al. Preparation, in vitro and in vivo evaluation of chitosan-sodium alginate-ethyl cellulose polyelectrolyte film as a novel buccal mucosal delivery vehicle. Eur J Pharm Sci. 2022;168:106085.","journal-title":"Eur J Pharm Sci"},{"key":"2838_CR25","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","volume":"14","author":"A Ahmed","year":"2020","unstructured":"Ahmed A, Tait SWG. Targeting immunogenic cell death in cancer. Mol Oncol. 2020;14:2994\u20133006.","journal-title":"Mol Oncol"},{"key":"2838_CR26","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, et al. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12:860\u201375.","journal-title":"Nat Rev Cancer"},{"key":"2838_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijpharm.2015.02.054","volume":"484","author":"L Wan","year":"2015","unstructured":"Wan L, et al. Folate-Polyethyleneimine functionalized mesoporous carbon nanoparticles for enhancing oral bioavailability of paclitaxel. Int J Pharm. 2015;484:207\u201317.","journal-title":"Int J Pharm"},{"key":"2838_CR28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","volume":"18","author":"J Borst","year":"2018","unstructured":"Borst J, Ahrends T, B\u0105ba\u0142a N, Melief CJM, Kastenm\u00fcller. W. CD4\u2009+\u2009T cell help in cancer immunology and immunotherapy. Nat Rev Immunol. 2018;18:635\u201347.","journal-title":"Nat Rev Immunol"},{"key":"2838_CR29","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.immuni.2017.10.009","volume":"47","author":"T Ahrends","year":"2017","unstructured":"Ahrends T, et al. CD4\u2009+\u2009T cell help confers a cytotoxic T cell Effector Program including coinhibitory receptor downregulation and increased tissue invasiveness. Immunity. 2017;47:848\u2013e8615.","journal-title":"Immunity"},{"key":"2838_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coi.2017.01.002","volume":"45","author":"F Veglia","year":"2017","unstructured":"Veglia F, Gabrilovich DI. Dendritic cells in cancer: the role revisited. Curr Opin Immunol. 2017;45:43\u201351.","journal-title":"Curr Opin Immunol"},{"key":"2838_CR31","doi-asserted-by":"publisher","first-page":"733","DOI":"10.4049\/jimmunol.1901121","volume":"204","author":"CA Iberg","year":"2020","unstructured":"Iberg CA, Hawiger D. Natural and Induced Tolerogenic dendritic cells. J Immunol. 2020;204:733\u201344.","journal-title":"J Immunol"},{"key":"2838_CR32","first-page":"2679","volume":"21","author":"M Yamazaki","year":"1994","unstructured":"Yamazaki M. [TNF-alpha]. Gan Kagaku Ryoho. 1994;21:2679\u201387.","journal-title":"Gan Kagaku Ryoho"},{"key":"2838_CR33","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3390\/v13061137","volume":"13","author":"N Otani","year":"2021","unstructured":"Otani N, et al. Changes in cell-mediated immunity (IFN-\u03b3 and Granzyme B) following influenza vaccination. Viruses. 2021;13:1137.","journal-title":"Viruses"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02838-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-02838-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02838-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T05:06:23Z","timestamp":1726117583000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-02838-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2838"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-02838-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"558"}}